Surgical treatment of Parkinson's disease

Journal of the Neurological Sciences

Volumn 167, Issue 1, 1999, Pages 1-10

  Koller, William C ^a   Pahwa, Rajesh ^a   Lyons, Kelly E ^a   Albanese, Alberto ^b  

^a UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^b Department of Neurology ^*  (Switzerland)

Author keywords

Deep brain stimulation; Pallidotomy; Parkinson's disease; Subthalamus; Thalamotomy; VIM nucleus

Indexed keywords

BRAIN DEPTH STIMULATION; HUMAN; METHODOLOGY; PALLIDOTOMY; PARKINSON DISEASE; PRIORITY JOURNAL; REVIEW; STEREOTAXIC SURGERY; SUBTHALAMIC NUCLEUS; THALAMOTOMY;

BRAIN TISSUE TRANSPLANTATION; FETAL TISSUE TRANSPLANTATION; GLOBUS PALLIDUS; HUMANS; NEURONS; PARKINSON DISEASE; SUBSTANTIA NIGRA; SUBTHALAMIC NUCLEUS; VENTRAL THALAMIC NUCLEI;

EID: 0032814827     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(99)00139-2     Document Type: Review

References (98)

1. Olanow CW, Koller WC. An algorithm for the management of Parkinson's disease. Neurology 1998;50:S1-S57.
2. DeLong MR. Primate models of movement disorders of basal ganglia origin. Trends Neurosci 1990;13:281-5.
3. Eidelberg D, Mueller J, Ishikawa T et al. Regional metabolic correlates of surgical outcome following unilateral pallidotomy for Parkinson's disease. Ann Neurol 1996;39:450-9.
4. Rodriguez R, Obeso J, Olanow CW. Subthalamic nucleus mediated excitotoxicity in Parkinson's disease. A target for neuroprotection. Ann Neurol 1998;44(Suppl 1):S 175-88.
5. Bucy PC, Case JT. Tremor: physiologic mechanism and abolition by surgical means. Arch Neurol Psychiat (Chicago) 1939;41:721-46.
6. Klemme RM. Surgical treatment of dystonia, paralysis agitans and athetosis. Arch Neurol Psychiat (Chicago) 1940;44:926.
7. Putnam TJ. Relief from unilateral paralysis agitans by section of the pyramidal tract. Arch Neurol Psychiat (Chicago) 1938;40:1049-50.
8. Walker AE. Cerebral pedunculotomy for the relief of involuntary movements. I.I. Parkinsonian tremor. J Nerv Ment Dis 1952;116:766-75.
9. Meyers R. Surgical procedure for postencephalitic tremor, with notes on the physiology of premotor fibres. Arch Neurol Psychiat (Chicago) 1940;44:455-7.
10. Meyers R. The modification of alternating tremors, rigidity and festination by surgery of the basal ganglia. Res Publ Assoc Res Nerv Ment Dis 1942;21:602-65.
11. Spiegel EA, Wycis HT, Marks M, Lee AJ. Stereotaxic apparatus for operations on the human brain. Science 1946; 106:349-59.
12. Spiegel EA, Wycis HT. Ansotomy in paralysis agitans. Arch Neurol Psychiat (Chicago) 1954;71:598-614.
13. Spiegel EA, Wycis HT, Baird HNWW. Long-range effects of electropalliodensotomy in extrapyramidal and convulsive disorders. Neurology 1958;8:734-40.
14. Hassler R, Reichert T. Indikationen und Lokalisationmethode dergezielten Hirnoperationen. Nervenarzt 1954;25:441-7.
15. Albe-Fessard D, Arfel G, Guiot G et al. Identification et délimitation précise de certaines structures sous-corticales de l'homme par l'électrophysiologie. Son interêt dans la chirurgie steréotaxique des dyskinésies. CR Acad Sci Paris 1961;253:2412-4.
16. Cooper IS. Intracerebral injection of procaine into the globus pallidus in hyperkinetic disorders. Science 1954;119:417-8.
17. Cooper IS. Surgical alleviation of parkinsonism: effects of occlusion of the anterior choroidal artery. J Am Geriatr Soc 1954; 11:691-717.
18. Svennilson E, Torvik A, Lowe R, Leksell L. Treatment of parkinsonism by stereotactic thermolesions in the paludal region. A clinical evaluation of 81 cases. Acta Psychiatr Neurol Scand 1960;35:358-77.
19. Laitinen LV, Bergenheim AT, Hariz MI. Leksell's posteroventral pallidotomy in the treatment of Parkinson's disease. J Neurosurg 1992;76:53-61.
20. Birkmayer W, Hornykiewicz O. Der L-3,4-Dioxyphenylalanin (=DOPA)-Effekt bei der Parkinson-Akinesie. Wien Klin Wochenschr 1961;73:785-6.
21. Cotzias GC, van Woert MH, Schiffer LM. Aromatic amino acids and modification of parkinsonism. New Engl J Med 1967;276:374-9.
22. Jankovic J, Cardoso F, Grossman RG, Hamilton WJ. Outcome after stereotactic thalamotomy for parkinsonian, essential, and other types of tremor. Neurosurgery 1995;37:680-6.
23. Selby G. Stereotaxic surgery. In: Koller WC, editor. Handbook of Parkinson's disease. New York: Marcel Dekker, 1987:421-35.
24. Cooper IS. Parkinsonism, its medical and surgical therapy, Spring-field, II: Charles C. Thomas, 1961.
25. Krayenbuhl H, Wyss OAM, Yasargil MG. Bilateral thalamotomy and pallidotomy as treatment for bilateral parkinsonism. J Neurosurg 1961;18:429.
26. Markham CH, Rand RW. Stereotactic surgery in Parkinson's disease. Arch Neurol 1963;44:621-31.
27. Bertrand C, Hardy J, Molina-Negro P, Martinez SN. Tremor of attitude. Confin Neurol 1969;31:37-41.
28. Kelly PJ, Gillingham FJ. The long-term results of Stereotaxic surgery and 1-dopa therapy in patients with Parkinson's disease: A 10 year follow-up study. J Neurosurg 1980;53:332-7.
29. Ohye C. Depth microelectrode studies. In. In: Schaltenbrand G, Walker AE, editors, Stereotaxy of the human brain, anatomical, physiological and clinical applications, Stuttgart: Georg Thieme, 1982, pp. 372-89.
30. Tasker RR, Siqueira J, Hawrylyshyn P, Organ LW. What happened to VIM thalamotomy for Parkinson's disease? Appl Neurophysiol 1983;46:68-83.
31. Matsumoto K, Shichijo F, Fukami T. Long-term follow-up review of cases of Parkinson's disease after unilateral or bilateral thalamotomy. J Neurosurg 1984;60:1033-44.
32. Nagaseki Y, Shibazaki T, Hirai T et al. Long-term follow-up results of selective VIM thalamotomy. J Neurosurg 1986;65:296-302.
33. Diederich N, Goetz CG, Stebbins GT et al. Blinded evaluation confirms long-term asymmetric effect of unilateral thalamotomy or subthalamotomy on tremor in Parkinson's disease. Neurology 1992;42:1311-4.
34. Hughes RC, Polgar JG, Weightman D et al. L-dopa in parkinsonism and the influence of previous thalamotomy. Br Med J 1971;1:7-13.
35. Lenz FA, Normand SL, Kwan HC et al. Statistical prediction of the optimal lesion site for thalamotomy in parkinsonian tremor. Mov Disord 1995;10:318-28.
36. Pollack P, Benabid AL, Limousin P, Benazzouz A. Chronic intracerebral stimulation in Parkinson's disease. Adv Neurol 1997;74:213-20.
37. Blond S, Caparros-Lefebvre D, Parker F et al. Control of tremor and involuntary movement disorders by chronic stereotactic stimulation of the ventral intermediate thalamic nucleus. J Neurosurg 1992;77:62-8.
38. Speelman JD, Bosch DA. Continuous electric thalamus stimulation for the treatment of tremor resistant to pharmacotherapy. Ned Tijdschr Geneeskd 1995;139:926-30.
39. Alesch F, Pinter MM, Helscher RJ et al. Stimulation of the ventral intermediate thalamic nucleus in tremor dominated Parkinson's disease and essential tremor. Acta Neurochir 1995;136:75-81.
40. Benabid AL, Pollak P, Gao D et al. Chronic electrical stimulation of the ventralis intermedius nucleus of the thalamus as a treatment of movement disorders. J Neurosurg 1996;84:203-14.
41. Koller W, Pahwa R, Busenbark K et al. High-frequency unilateral thalamic Stimulation in the treatment of essential and parkinsonian tremor. Ann Neurol 1997;42:292-9.
42. Ondo W, Jankovic J, Schwartz K et al. Unilateral thalamic deep brain stimulation for refractory essential tremor and Parkinson's disease tremor. Neurology 1998;51:1063-9.
43. Cooper IS. Ligation of the anterior choroidal artery for involuntary movements of parkinsonism. Psychiatr Q 1953;27:317-9.
44. Vitek JL. Stereotaxic surgery and deep brain stimulation for Parkinson's disease and movement disorders. In: Watts RL, Koller WC, editors, Movement disorders: neurologic principles and practice, New York: McGraw-Hill, 1997, pp. 237-55.
45. Dogali M, Fazzini E, Kolodny E et al. Stereotactic ventral pallidotomy for Parkinson's disease. Neurology 1995;45:753-61.
46. Lozano AM, Lang AE, Galvez-Jimenez N et al. Effect of GPi pallidotomy on motor function in Parkinson's disease. Lancet 1995;346:1383-7.
47. Baron MS, Vitek JL, Bakay RA et al. Treatment of advanced Parkinson's disease by posterior GPi pallidotomy: 1-year results of a pilot study. Ann Neurol 1996;40:355-66.
48. Kishore A, Turnbull IM, Snow BJ et al. Efficacy, stability and predictors of outcome of pallidotomy for Parkinson's disease. Six-month follow-up with additional 1-year observations. Brain 1997;120:729-37.
49. Lang AE, Lozano AM, Montgomery E et al. Posteroventral medial pallidotomy in advanced Parkinson's disease [see comments]. New Engl J Med 1997;337:1036-42.
50. Fazzini E, Dogali M, Sterio D et al. Stereotactic pallidotomy for Parkinson's disease: a long-term follow-up of unilateral pallidotomy. Neurology 1997;48:1273-7.
51. Uitti RJ, Wharen Jr. RE, Turk MF et al. Unilateral pallidotomy for Parkinson's disease: comparison of outcome in younger versus elderly patients. Neurology 1997;49:1072-7.
52. Ondo WG, Jankovic J, Lai EC et al. Assessment of motor function after stereotactic pallidotomy. Neurology 1998;50:266-70.
53. Shannon KM, Penn RD, Kroin JS et al. Stereotactic pallidotomy for the treatment of Parkinson's disease. Efficacy and adverse effects at 6 months in 26 patients. Neurology 1998;50:434-8.
54. Samuel M, Caputo E, Brooks DJ et al. A study of medial pallidotomy for Parkinson's disease: clinical outcome. MRI. location and complications. Brain 1998;121:59-75.
55. Masterman D, DeSalles A, Baloh RW et al. Motor, cognitive, and behavioral performance following unilateral ventroposterior pallidotomy for Parkinson disease. Arch Neurol 1998;55:1201-8.
56. Galvez-Jimenez N, Lozano AM, Duff J et al. Bilateral pallidotomy pronounced amelioration of incapacitating levodopa-induced dyskinesias but accompanying cognitive decline. Mov Disord 1996; 11:242.
57. Roberts JW, Heilbrun MP. Staged bilateral ventroposterior pallidotomy for Parkinson's disease [Abstract]. Neurology 1997;48:A358.
58. Kumar R, Lozano AM, Montgomery E, Lang AE. Pallidotomy and deep brain stimulation of the pallidum and subthalamic nucleus in advanced Parkinson's disease. Mov Disord 1998;13:73-82.
59. Olanow CW. GPi pallidotomy-have we made a dent in Parkinson's disease? [editorial; comment]. Ann Neurol 1996;40:341-3.
60. Bakay RA, DeLong MR, Vitek JL. Posteroventral pallidotomy for Parkinson's disease [letter; comment]. J Neurosurg 1992;77:487-8.
61. Laitinen LV, Bergenheim AT, Hariz MI. Ventroposterolateral pallidotomy can abolish all parkinsonian symptoms. Stereotact Funct Neurosurg 1992;58:14-21.
62. Kazumata K, Antonini A, Dhawan V et al. Preoperative indicators of clinical outcome following stereotaxic pallidotomy. Neurology 1997;49:1083-90.
63. Siegfried J, Lippitz B. Chronic electrical stimulation of the VL-VPL complex and of the pallidum in the treatment of movement disorders: personal experience since 1982. Stereotact Funct Neurosurg 1994;62:71-5.
64. Pahwa R, Wilkinson S, Smith D et al. High-frequency stimulation of the globus pallidus for the treatment of Parkinson's disease. Neurology 1997;49:249-53.
65. Gross C, Rougier A, Guehl D et al. High-frequency stimulation of the globus pallidus internalis in Parkinson's disease: a study of seven cases. J Neurosurg 1997;87:491-8.
66. Krack P, Pollak P, Limousin P et al. Subthalamic nucleus or internal paludal stimulation in young onset Parkinson's disease. Brain 1998;121:451-7.
67. Kumar R, Lozano AM, Duff J et al. Comparison of the effects of microelectrode-guided posteroventral medial pallidotomy and globus internus deep brain stimulation. Neurology 1997;48(suppl):A430.
68. Merello M, Nouzeilles MI, Kuzis G et al. Unilateral radiofrequency lesion versus electrostimulation of posteroventral pallidum: a prospective randomized comparison. Mov Disord 1999;14:50-6.
69. Obeso JA, Alvarez CM, Marcins RJ et al. Lesions of the subthalamic nucleus (STN) in Parkinson's disease (PD). Neurology 1997;48:A136.
70. Gill SS, Heywood P. Bilateral dorsolateral subthalamotomy for advanced Parkinson's disease. Lancet 1997;350:1224.
71. Kumar R, Lozano AM, Kim YJ et al. Double-blind evaluation of subthalamic nucleus deep brain stimulation. Mov Disord 1998;13:907-14.
72. Limousin P, Krack P, Pollak P et al. Electrical Stimulation of the subthalamic nucleus in advanced Parkinson's disease. New Engl J Med 1998;339:1105-11.
73. Peschanski M, Cesaro P, Hantraye P. Rationale for intrastriatal grafting of striatal neuroblasts in patients with Huntington's disease. Neuroscience 1995;68:273-85.
74. Lindvall O. Neural transplantation. Cell Transplant 1995;4:393-400.
75. Olanow CW, Lordower JH, Freeman TB. Fetal nigral transplantation as a therapy for Parkinson's disease. Trends Neurosci 1996; 19:102-9.
76. Björklund A, Stenevi U. Reconstruction of the nigrostriatal dopamine pathway by intracerebral nigral transplants. Brain Res 1979:177:555-60.
77. Dunnett SB, Björklund A. Mechanism of function of neural grafts in the adult mammalian brain. J Exp Biol 1987;132:265-89.
78. Freed WJ, Morihisa JM, Spoor E et al. Transplanted adrenal chromaffin cells in rat brain reduce lesion-induced rotational behaviour. Nature 1981;292:351-2.
79. Backlund EO, Granberg PO, Hamberger B et al. Transplantation of adrenal medullary tissue to striatum in parkinsonism. First clinical trials. J Neurosurg 1985;62:169-73.
80. Madrazo I, Drucker-Colin R, Diaz V, Martinez-Mata J, Torres C, Becerril JJ. Open microsurgical autograf of adrenal medulla to the right caudate nucleus in two patient with intractable Parkinson's disease. New Engl J Med 1987;316:831-4.
81. Allen GS, Burns RS, Tulipan NB, Parker RA. Adrenal medullary transplantation to the caudate nucleus in Parkinson's disease. Initial clinical results in 18 patients. Arch Neurol 1989;46(5):487-91.
82. Björklund A, Schmidt RH, Stenevi U. Functional reinnervation of the neostriatum in the adult rat by use of intraparenchymal grafting of dissociated cell suspensions from the substantia nigra. Cell Tissue Res 1980;212:39-45.
83. Dunnett SB, Björklund A, Schmidt RH, Stenevi U, Iversen SD. Intracerebral grafting of neuronal cell suspensions. I.V. Behavioural recovery in rats with unilateral 6-OHDA lesions following implantation of nigral cell suspensions in different forebrain sites. Acta Physiol Scand Suppl 1983;522:29-37.
84. Jaeger CB. Cytoarchitectonics of substantia nigra grafts: a light and electron microscopic study of immunocytochemically identified dopaminergic neurons and fibrous astrocytes. J Comp Neurol 1985;231:121-35.
85. Freund TF, Bolam JP, Björklund A et al. Efferent synaptic connections of grafted dopaminergic neurons reinnervating the host neostriatum: a tyrosine hydroxylase immunocytochemical study. J Neurosci 1985;5:603-16.
86. Mahalik TJ, Finger TE, Stromberg I, Olson L. Substantia nigra transplants into denervated striatum of the rat: ultrastructure of graft and host interconnections. J Comp Neurol 1985;240:60-70.
87. Kordower JH, Freeman TB, Snow BJ et al. Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease. New Engl J Med 1995;332:1118-24.
88. Sladek JR, Collier TJ, Haber SN, Roth RH, Redmond DE. Survival and growth of fetal catecholamine neurons transplanted into primate brain. Brain Res Bull 1986;17:809-18.
89. Lindvall O, Rehncrona S, Brundin P et al. Human fetal dopamine neurons grafted into the striatum in two patients with severe Parkinson's disease. A detailed account of methodology and a 6-month follow-up. Arch Neurol 1989;46:615-31.
90. Tabbal S, Fahn S, Frucht S. Fetal tissue transplantation in Parkinson's disease. Curr Opin Neurol 1998;11:341-9.
91. Moller JC, Sautter J, Kupsch A. Potential of neurotrophic factors in therapy of Parkinson's disease. J Neur Transm Suppl 1996;48:103-12.
92. Casper D, Mytilineou C, Blum M. EGF enhances the survival of dopamine neurons in rat embryonic mesencephalon primary cell culture. J Neurosci Res 1991;30:372-81.
93. Lapchak PA. A preclinical development strategy designed to optimize the use of glial cell line-derived neurotrophic factor in the treatment of Parkinson's disease. Mov Disord 1998;13 Supplement 1:49-54.
94. Othberg AI, Willing AE, Cameron DF et al. Trophic effect of porcine Sertoli cells on rat and human ventral mesencephalic cells and hNT neurons in vitro. Cell Transplant 1998;7:157-64.
95. Lindvall O. Neural transplantation: a hope for patient with Parkinson's disease. Neuroreport 1997;8:R3-R10.
96. Galpern WR, Burns LH, Deacon TW, Dinsmore J, Isacson O. Xenotransplantation of porcine fetal ventral mesencephalon in a rat model of Parkinson's disease: functional recovery and graft morphology. Exp Neurol 1996;140:1-13.
97. Weiss S, Reynolds BA.Vescovi AL, Morshead C, Craig CG, van der Kooy D. Is there a neural stem cell in the mammalian forebrain? Trends Neurosci 1996;19:387-93.
98. Azizi SA, Stokes D, Augelli BJ, DiGirolamo C, Prockop DJ. Engraftment and migration of human bone marrow stromal cells implanted in the brains of albino rats: similarities to astrocyte grafts. Proc Natl Acad Sci USA 1998;95:3908-13.